Reaction
Pulmonary Artery Thrombosis reporting signals
As of the last recalculation, Pulmonary Artery Thrombosis appears in 762 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 30.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 17 | 30.3 | 30.3 |
| Heparin Sodium | 13 | 26.2 | 26.3 |
| Irinotecan Hydrochloride | 11 | 23.7 | 23.7 |
| Trifluridine And Tipiracil | 8 | 20.6 | 20.6 |
| Pemetrexed | 14 | 18.1 | 18.2 |
| Crizotinib | 8 | 17.4 | 17.4 |
| Drospirenone And Ethinyl Estradiol | 25 | 15.9 | 16.0 |
| Fluorouracil Cream, 0.5% | 41 | 15.5 | 15.5 |
| Fluorouracil | 41 | 15.2 | 15.3 |
| Pemetrexed Disodium | 20 | 14.7 | 14.7 |
| Baricitinib | 5 | 14.3 | 14.3 |
| Eltrombopag Olamine | 11 | 13.2 | 13.2 |
| Gemcitabine Hydrochloride | 19 | 10.0 | 10.0 |
| Durvalumab | 7 | 9.5 | 9.5 |
| Alteplase | 5 | 9.1 | 9.2 |
| Encorafenib | 3 | 8.3 | 8.3 |
| Osimertinib | 8 | 6.9 | 6.9 |